AlphaYouGR
Insider selling
Gilead Raday sold $2K of RedHill Biopharma Ltd. (RDHL) stock
Gilead Raday, Chief Operating Officer of RedHill Biopharma Ltd. (RDHL), sold 15,740,000 shares of RDHL stock worth $2K, per an SEC Form 4 filed Apr 22, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 6, 2026, 16 days before it was made public.
RDHL has moved -40.6% since the trade date, from $0.83 to $0.49 (Oct 5, 2026 close).
- Traded
- Apr 6, 2026
- Disclosed
- Apr 22, 2026
- Filing delay
- 16 days
- Price since
- -40.6%
- Role
- Chief Operating Officer
- Source
- SEC Form 4
More RDHL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.